Welcome to the DZIF -

the German Center for Infection Research

Information on SARS-CoV-2

Visit page

Research Areas

DZIF is doing research in nine areas:


News and Press Releases.

idt Abfüllanlage
© Hartmut Bösener/IDT Biologika

UNITE4TB marks a new era in tuberculosis treatment development

To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has
Stefan Niemann
© FZ Borstel/Pukall

Stefan Niemann receives the Gardner Middlebrook Award 2021

The molecular biologist Prof. Stefan Niemann from the Research Center Borstel, Leibniz Lung Center was honored with the Gardner Middlebrook Lifetime Achievement Award. The award was presented online
Autophagie und SARS
© UKB/Daniel Heinz

A tapeworm drug against SARS-CoV-2?

Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism
Team um Jan Rybniker
© Uniklinik Köln, Foto: Christoph Wanko

Long-lasting and profound reprogramming of immune cells after COVID-19

SARS-CoV-2 infection causes severe inflammation of the lungs and other vital organs. Why some infected individuals respond with an exaggerated immune response to the virus remains not well understood

The DZIF at a glance:

United against infections

Learn more about the German Center for Infection Research (DZIF) and the four grand infectious disease challenges of our time:

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Image of a microfilaria of the roundworm Loa Loa, taken at 100x magnification.
© Marc Hübner/UK Bonn
image jpeg (206.95 KB)

Loa loa

jpeg (206.95 KB)

Research in Focus

Our Partner Sites

Databases- & Biobanks 2019